Chronic Intestinal Pseudo‑Obstruction (CIPO)

Overview

CIPO is a heterogeneous disorder of gut motility characterized by recurrent or persistent signs of mechanical bowel obstruction without a fixed, lumen‑occluding lesion. Pediatric cases are often congenital or genetic and carry high risks of malnutrition, infection, and intestinal failure.

Core concepts

• Repeated or continuous signs of obstruction without an anatomic blockage.
• Heterogeneous group of disorders sharing similar presentation, evaluation, and management.
• Primary (intrinsic neuropathic/myopathic/mesenchymopathic) or secondary (systemic disease, infection, ischemia, medication, postoperative).
• Mechanistic classification: neuropathic, myopathic, or mesenchymopathic (interstitial cells of Cajal); mixed forms and evolution between types are common.

Presentation

• Common symptoms: abdominal distention (85%–98%), vomiting (55%–91%), constipation (50%–77%), abdominal pain (58%–70%), poor weight gain/failure to thrive (27%–72%).
• Episodes of exacerbation separated by periods of improvement; can mimic intermittent mechanical obstruction.
• Most children present within the first year of life (65%–76%), but later onset occurs.
• Associated features: urinary tract involvement, intestinal malrotation, feeding intolerance, risk of small‑bowel bacterial overgrowth (SIBO).
• Consider syndromes: megacystic‑microcolon‑intestinal hypoperistalsis (GI dysmotility + urinary tract involvement + microcolon) and neuromuscular/mitochondrial or connective tissue disorders.

Evaluation

Initial priorities

• Exclude mechanical obstruction and surgical emergencies promptly.
• Assess hemodynamic status, dehydration, electrolyte abnormalities, and need for decompression.

Radiology

• Plain abdominal radiographs: gaseous distention and air‑fluid levels.
• Contrast studies (contrast follow‑through, enema): exclude fixed obstruction and demonstrate slow transit through featureless intestine.
• Cross‑sectional imaging (CT or MR enterography): evaluate for focal lesions, complications, or alternate diagnoses.

Motility testing

• Antroduodenal and colonic manometry: identify affected segments, distinguish neuropathic from myopathic patterns, guide prognosis and management.
• Best performed during periods of clinical stability; abnormal antroduodenal manometry is common in CIPO.
• Presence of phase III of the migrating motor complex (MMC) correlates with improved enteral‑feeding tolerance and survival.

Other diagnostic tools

• Full‑thickness intestinal biopsy (surgical): reserved for selected cases to define neuropathic vs myopathic pathology when results will alter management.
• Endoscopy with mucosal biopsies: exclude mucosal disease and collect specimens for targeted testing.
• Laboratory testing: metabolic panel, thyroid, inflammatory markers, lactate (mitochondrial disease), infection workup, and autoantibodies as indicated.
• Genetic testing: targeted panels or exome sequencing when congenital syndromes or familial forms are suspected (eg, FLNA, ACTG2 and others).
• SIBO testing: breath tests are limited in children; consider empiric antibiotic trial guided by clinical suspicion.
• Baseline nutritional and bone health assessment in all children with chronic disease.

Management

Management is multidisciplinary, individualized, and focused on symptom control, complication prevention, nutritional support, and preserving enteral feeding when possible.

Acute management of flares

• Hospitalize for severe distention, intractable vomiting, dehydration, or suspected sepsis.
• Decompression with nasogastric or nasoenteric tube; aggressive fluid and electrolyte repletion.
• Exclude surgical causes; reserve surgery for perforation, ischemia, or focal anatomic lesions unresponsive to conservative care.
• Treat infections and SIBO; obtain cultures and begin empiric antibiotics if clinically indicated.

Pharmacologic therapies

• Prokinetics (select by target segment and age):
  
• Erythromycin (motilin agonist) for gastric dysmotility
• Prucalopride or other 5‑HT4 agonists for colonic motility where available
• Cisapride has efficacy but major cardiac safety restrictions where used
• Octreotide and acetylcholinesterase inhibitors (neostigmine, pyridostigmine) in specific settings.
• Avoid or minimize opioids; prefer multimodal analgesia and involve pain specialists.
• Antiemetics and acid suppression as symptom control measures.
• Antibiotics for SIBO: rifaximin where available or systemic antibiotics guided by response and local practice.
• Aggressive constipation management with osmotic laxatives, stool softeners, and enemas tailored to patient physiology.

Nutritional management

• Early involvement of pediatric nutrition support and dietitian services.
• Enteral feeding (nasojejunal, gastrostomy‑jejunostomy) preferred when tolerated to preserve gut integrity and reduce PN dependence.
• Parenteral nutrition (PN) when enteral support is insufficient; plan for long‑term PN with central line care bundles and monitored strategies to prevent PN‑associated liver disease and catheter infections.
• Monitor growth, electrolytes, vitamins (including fat‑soluble), trace elements, and bone health; supplement and treat deficiencies.
• Use cyclic PN and lipid modification strategies to reduce cholestasis risk where appropriate.

Surgical and interventional options

• Gastrostomy and/or jejunostomy for decompression, feeding, and medication administration; consider venting gastrostomy for massive gastric dilation.
• Ileostomy to lower small‑intestinal pressure and bypass colon in select patients.
• Avoid unnecessary resections; multiple prior operations are common and may worsen motility.
• Intestinal transplantation for life‑threatening PN complications (recurrent catheter sepsis, PN‑associated liver failure, loss of central access) or irreversible intestinal failure; refer early to transplant centers.
• Liver transplantation for PN‑associated end‑stage liver disease as indicated.

Complication prevention and long‑term strategies

• Prevent and treat SIBO; individualize prophylaxis versus symptomatic therapy.
• Strict central line care, family education, and infection surveillance to reduce catheter‑related bloodstream infections.
• Surveillance for PN‑associated cholestasis and fibrosis; apply lipid reduction and cycling strategies.
• Bone health monitoring and treatment for osteopenia/osteoporosis with endocrine input.
• Psychosocial and developmental support for patient and caregivers due to chronic care burden.

Prognosis, outcomes, and follow‑up

• Highly variable prognosis depending on etiology, extent of involvement, enteral‑feeding tolerance, and complications from PN and central lines.
• Poorer outcome predictors: diffuse neonatal onset, inability to maintain enteral nutrition, recurrent catheter sepsis, progressive PN‑associated liver disease, and absent preserved motor patterns on manometry.
• Follow‑up: frequent multidisciplinary review; growth and nutrition checks every 1–3 months when unstable; individualized schedules for stable children.
• Coordinate early with regional intestinal and liver transplant teams for children approaching criteria for referral.

Practical clinical pearls

• Suspect CIPO in infants with recurrent radiographic obstruction without anatomic cause or children with persistent failure to thrive and severe dysmotility.
• Prioritize noninvasive diagnostics and motility testing before repeated exploratory surgeries; avoid unnecessary resections.
• Perform manometry during stable intervals to optimize diagnostic yield and prognostic value; preserved phase III MMC activity predicts better outcomes.
• Start nutritional planning early; prioritize enteral feeding and escalate to PN with protective strategies only when necessary.
• Minimize opioid exposure; involve pain management and behavioral therapies for chronic pain and feeding difficulties.
• Obtain genetic testing when congenital or syndromic causes are suspected to guide counseling and associated screening.
• Engage transplant centers early for children with progressive intestinal failure or severe PN complications.

Suggested implementation items for a pediatric clinic

• Local CIPO pathway: emergency triage criteria, imaging and motility testing sequence, and indications for surgical consultation.
• Nutrition support protocol: enteral feeding algorithms, PN initiation and monitoring, central line care bundles, and growth tracking templates.
• Manometry and biopsy referral guidelines: when to request testing and how results should change management.
• Transplant referral checklist: triggers for early transplant center discussion (recurrent line sepsis, PN cholestasis, loss of central venous access, failure of enteral nutrition).
• Family education materials: central line care, signs of catheter infection, feeding strategies, and psychosocial supports.